• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重发热伴血小板减少综合征病毒感染患者凝血时间延长,提示肝素样作用和出血风险增加。

Prolonged coagulation times in severe fever with thrombocytopenia syndrome virus infection, the indicators of heparin-like effect and increased haemorrhagic risk.

机构信息

Department of Clinical Laboratory, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Department of Hematology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Br J Haematol. 2024 May;204(5):1999-2006. doi: 10.1111/bjh.19364. Epub 2024 Mar 4.

DOI:10.1111/bjh.19364
PMID:38438264
Abstract

Prolonged coagulation times, such as activated partial thromboplastin time (APTT) and thrombin time (TT), are common in patients infected with severe fever with thrombocytopenia syndrome virus (SFTSV) and have been confirmed to be related to patient's poor outcome by previous studies. To find out the reason for prolonged coagulation time in patients with SFTSV infection, and whether it predicts haemorrhagic risk or not. Seventy-eight consecutive patients with confirmed SFTSV infection were enrolled in this prospective, single-centre, observational study. Several global and specific coagulation parameters of these patients on admission were detected, and the haemorrhagic events during hospitalization and their outcomes were recorded. Most of the enrolled patients had prolonged APTT (82.1%) and TT (80.8%), normal prothrombin time (83.3%) and intrinsic coagulation factors above haemostatic levels (97.4%). The heparin-like effect was confirmed by a protamine neutralization test and anti-Xa activity detection in most patients. Interestingly, the APTT and TT results were significantly positively correlated with the levels of endothelial markers and viral load, respectively. The APTT was independently associated with the haemorrhage of patients. The prolonged APTT and TT of SFTS patients may mainly be attributed to endogenous heparinoids and are associated with increased haemorrhagic risk.

摘要

凝血时间延长,如活化部分凝血活酶时间(APTT)和凝血酶时间(TT),在感染严重发热伴血小板减少综合征病毒(SFTSV)的患者中很常见,并且之前的研究已经证实与患者的不良预后有关。为了找出 SFTSV 感染患者凝血时间延长的原因,以及是否预测出血风险。本前瞻性、单中心、观察性研究纳入了 78 例确诊的 SFTSV 感染连续患者。检测了这些患者入院时的几项全球和特定凝血参数,并记录了住院期间的出血事件及其结局。大多数入组患者的 APTT(82.1%)和 TT(80.8%)延长,凝血酶原时间正常(83.3%),内在凝血因子高于止血水平(97.4%)。大多数患者的鱼精蛋白中和试验和抗 Xa 活性检测证实存在肝素样效应。有趣的是,APTT 和 TT 结果分别与内皮标志物和病毒载量水平呈显著正相关。APTT 与患者出血独立相关。SFTS 患者的 APTT 和 TT 延长可能主要归因于内源性肝素类物质,与出血风险增加有关。

相似文献

1
Prolonged coagulation times in severe fever with thrombocytopenia syndrome virus infection, the indicators of heparin-like effect and increased haemorrhagic risk.严重发热伴血小板减少综合征病毒感染患者凝血时间延长,提示肝素样作用和出血风险增加。
Br J Haematol. 2024 May;204(5):1999-2006. doi: 10.1111/bjh.19364. Epub 2024 Mar 4.
2
Why does activated partial thromboplastin time prolongation occur in severe fever with thrombocytopenia syndrome?为什么在重型发热伴血小板减少综合征中会出现活化部分凝血活酶时间延长?
BMJ Case Rep. 2020 Oct 8;13(10):e235447. doi: 10.1136/bcr-2020-235447.
3
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.AST/ALT 比值(De Ritis 比值)反映了早期发热伴血小板减少综合征患者的不良预后:一项观察性队列研究。
Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022.
4
Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis.严重发热伴血小板减少综合征患者的临床实验室参数与病死率:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2022 Jun 17;16(6):e0010489. doi: 10.1371/journal.pntd.0010489. eCollection 2022 Jun.
5
The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection.严重发热伴血小板减少综合征病毒(SFTSV)感染的临床和免疫学特征。
Clin Immunol. 2023 Mar;248:109262. doi: 10.1016/j.clim.2023.109262. Epub 2023 Feb 14.
6
A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies.发热伴血小板减少综合征、活化部分凝血活酶时间延长伴一过性抗磷脂抗体患者
Intern Med. 2023 Jul 15;62(14):2145-2149. doi: 10.2169/internalmedicine.0782-22. Epub 2022 Dec 7.
7
Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.关于鱼精蛋白对人凝血系统激活部位的普通肝素和低分子量肝素(速避凝)的中和作用的研究。
Thromb Haemost. 1995 Mar;73(3):439-43.
8
[Severe Fever With Thrombocytopenia Syndrome and Associated Encephalopathy].[严重发热伴血小板减少综合征及相关脑病]
Brain Nerve. 2022 Oct;74(10):1189-1195. doi: 10.11477/mf.1416202207.
9
Kinetics of Serological Response in Patients with Severe Fever with Thrombocytopenia Syndrome.严重发热伴血小板减少综合征患者血清学反应动力学。
Viruses. 2020 Dec 25;13(1):6. doi: 10.3390/v13010006.
10
[Clinical features and significance of coagulation dysfunction in severe fever with thrombocytopenia syndrome].[重症发热伴血小板减少综合征凝血功能障碍的临床特征及意义]
Zhonghua Nei Ke Za Zhi. 2022 Jul 1;61(7):793-796. doi: 10.3760/cma.j.cn112138-20211013-00702.

引用本文的文献

1
Dynamic changes of activated partial thromboplastin time and correlation with mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study.发热伴血小板减少综合征患者活化部分凝血活酶时间的动态变化及其与死亡率的相关性:一项回顾性队列研究
PLoS Negl Trop Dis. 2025 May 22;19(5):e0013106. doi: 10.1371/journal.pntd.0013106. eCollection 2025 May.
2
Evolving therapeutic strategies for severe fever with thrombocytopenia syndrome: from past to future.发热伴血小板减少综合征的治疗策略演变:从过去到未来
Ther Adv Infect Dis. 2025 May 16;12:20499361251340786. doi: 10.1177/20499361251340786. eCollection 2025 Jan-Dec.
3
Clinical characteristics and outcomes of disseminated intravascular coagulation in patients with severe fever with thrombocytopenia syndrome.
严重发热伴血小板减少综合征患者弥散性血管内凝血的临床特征及预后
BMC Infect Dis. 2025 Apr 11;25(1):508. doi: 10.1186/s12879-025-10900-y.
4
Biomarkers for Early Predicting In-Hospital Mortality in Severe Fever with Thrombocytopenia Syndrome and Differentiating It from Hemorrhagic Fever with Renal Syndrome.用于早期预测严重发热伴血小板减少综合征院内死亡率并将其与肾综合征出血热相鉴别的生物标志物。
Infect Drug Resist. 2025 Mar 12;18:1355-1366. doi: 10.2147/IDR.S492942. eCollection 2025.
5
Lactate dehydrogenase to albumin ratio (LAR) is a novel predictor of fatal outcome in patients with SFTS: an observational study.乳酸脱氢酶与白蛋白比值(LAR)是严重发热伴血小板减少综合征患者死亡结局的新型预测指标:一项观察性研究。
Front Public Health. 2024 Dec 17;12:1459712. doi: 10.3389/fpubh.2024.1459712. eCollection 2024.
6
Comparative analysis of the color change in blue-green inclusions within neutrophils between two patients with different clinical outcomes.比较分析两名临床结局不同患者中性粒细胞内蓝绿色包涵体的颜色变化。
Biochem Med (Zagreb). 2024 Oct 15;34(3):030801. doi: 10.11613/BM.2024.030801. Epub 2024 Aug 5.
7
A Prospective Study of the Association of IL6 with the Critical Unit and Their Effect on in-Hospital Mortality in Critically Ill Patients.IL6与重症监护病房的关联及其对重症患者院内死亡率影响的前瞻性研究。
Int J Gen Med. 2024 Jul 24;17:3257-3268. doi: 10.2147/IJGM.S474250. eCollection 2024.